SYNLAB AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.09 EUR | -0.09% |
|
+0.18% | -2.63% |
| 06-10 | After cyber attack: British hospitals urgently need blood donations | DP |
| 06-04 | Hackers attack laboratory chain Synlab again: 'repercussions' for patients | DP |
| Sales 2024 * | 2.86B 3.07B 4.21B | Sales 2025 * | 3.02B 3.24B 4.45B | Capitalization | 2.44B 2.62B 3.59B |
|---|---|---|---|---|---|
| Net income 2024 * | 81M 86.87M 119M | Net income 2025 * | 67M 71.86M 98.52M | EV / Sales 2024 * | 1.37 x |
| Net Debt 2024 * | 1.47B 1.58B 2.16B | Net Debt 2025 * | 1.64B 1.76B 2.41B | EV / Sales 2025 * | 1.35 x |
| P/E ratio 2024 * |
30
x | P/E ratio 2025 * |
37
x | Employees | 27,000 |
| Yield 2024 * |
1.85% | Yield 2025 * |
1.85% | Free-Float | 14.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on SYNLAB AG
More press releases
More news
| 1 day | -0.09% | ||
| 1 week | +0.18% | ||
| Current month | +0.36% | ||
| 1 month | +7.75% | ||
| 3 months | -0.80% | ||
| 6 months | -3.81% | ||
| Current year | -2.63% |
1 week
11.04
11.32
1 month
10.2611.32
Current year
10.1012.43
1 year
8.0212.43
3 years
6.6825.00
5 years
6.6825.00
10 years
6.6825.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 21-01-25 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 21-01-25 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 21-01-10 |
| Founder | 63 | 97-12-31 | |
Marc Welters
BRD | Director/Board Member | - | 21-04-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 125 M€ | -.--% | - | |
| 0.55% | 17 M€ | -.--% | - | |
| 0.18% | 18 M€ | +7.68% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-20 | 11.12 | +0.18% | 17 235 |
| 24-06-19 | 11.1 | +0.18% | 120,063 |
| 24-06-18 | 11.08 | -0.18% | 73,091 |
| 24-06-17 | 11.1 | +0.18% | 43,162 |
| 24-06-14 | 11.08 | -0.18% | 78,443 |
Delayed Quote Xetra, June 20, 2024 at 07:32 am
More quotes
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Calendar
2024-08-07
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.1
EUR
Average target price
14.5
EUR
Spread / Average Target
+30.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.63% | 2.62B | |
| -16.71% | 8.53B | |
| +67.76% | 4.31B | |
| +4.70% | 2.67B | |
| -53.41% | 1.87B | |
| -19.59% | 1.66B | |
| -21.62% | 1.41B | |
| +16.16% | 1.2B | |
| -46.45% | 1.09B | |
| +14.14% | 954M |
- Stock Market
- Equities
- SYAB Stock
